Shacey Petrovic — President and Chief Operating Officer at Insulet Corporation

Ms. Shacey Petrovic is the President and Chief Operating Officer of Insulet Corporation since October, 2016. Previously, she served as its Executive Vice President and President of Diabetes Products from February 2016 until October, 2016. Ms. Petrovic served as the Chief Commercial Officer at Insulet Corporation since February 10, 2015 until February 2016. She served as a Senior Advisor at Pritzker Group Private Capital and worked closely with the healthcare investment team. She served two years as the Chief Executive Officer and President of Clinical Innovations, LLC. Her track record of increasing sustainable profitability aligns perfectly with Clinical Innovation's growth strategy. She joined Clinical Innovations from Hologic, where she served as Vice President and General Manager of its gynecologic surgical division. As Hologic's Vice President of global surgical marketing, she led a direct-to-consumer advertising campaign and the integration of Interlace Medical. She has execution skills and a proven ability to grow product lines and lead top performing teams. Prior to her tenure with Hologic, she served in sales and marketing leadership roles in the United States and Europe for Cytyc Corporation. She served in a number of key roles during 13 years at Hologic, Inc. and Cytyc Corporation. Ms. Petrovic served as an award-winning Pharmaceutical Sales Specialist at AstraZeneca. Ms. Petrovic's 15 years of progressive leadership in the healthcare industry includes global successes in new business development as well as product and market launches. She has a long track record of success within commercial operations, including new product introduction, market share growth and business development. She is a seasoned expert with nearly two decades of experience in the medical device industry. She earned her B.S. in Biology from the University of Wisconsin - Madison.